» Articles » PMID: 9502631

Assessment of Diagnostic Performance of Quantitative Flow Measurements in Normal Subjects and Patients with Angiographically Documented Coronary Artery Disease by Means of Nitrogen-13 Ammonia and Positron Emission Tomography

Overview
Date 1998 Mar 21
PMID 9502631
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Regional myocardial blood flow (MBF) and flow reserve measurements using nitrogen-13 (N-13) ammonia positron emission tomography (PET) were compared with quantitative coronary angiography to determine their utility in the detection of significant coronary artery disease (CAD).

Background: Dynamic PET protocols using N-13 ammonia allow regional quantification of MBF and flow reserve. To establish the diagnostic performance of this method, the sensitivity and specificity must be known for varying decision thresholds.

Methods: MBF and flow reserve for three coronary territories were determined in 20 normal subjects and 31 patients with angiographically documented CAD by means of dynamic PET and a three-compartment model for N-13 ammonia kinetics. Ten normal subjects defined the normal mean and SD of MBF and flow reserve, and 10 normal subjects were compared with patients. PET flow obtained in the territory with the most severe stenosis in each patient was correlated with the angiographic assessment of the stenosis (severity > or = 50%, > or = 70%, > or = 90%). Receiver operating characteristic (ROC) curve analysis was performed for 1.5, 2.0, 2.5, 3.0 and 4.0 SD of flow abnormalities.

Results: MBF and flow reserve values from the normal subjects and from territories with documented stenoses > or = 50% were significantly different (p < 0.05). A significant difference was found between normal subjects and angiographically normal territories of patients with CAD. High diagnostic accuracy and sensitivity, with moderately high specificity, were demonstrated for detection of all stenoses.

Conclusions: Quantification of myocardial perfusion using dynamic PET and N-13 ammonia provides a high performance level for the detection and localization of CAD. The specificity of dynamic PET was excellent in patients with a low likelihood of CAD, whereas an abnormal flow reserve in angiographically normal territories was postulated to represent early functional abnormalities of vascular reactivity.

Citing Articles

Development and validation of a machine learning model to predict myocardial blood flow and clinical outcomes from patients' electrocardiograms.

Alahdab F, Saad M, Ahmed A, Al Tashi Q, Aminu M, Han Y Cell Rep Med. 2024; 5(10):101746.

PMID: 39326409 PMC: 11513811. DOI: 10.1016/j.xcrm.2024.101746.


Clinical Impact of Assessment of Myocardial Flow Reserve in Identifying the Cause of Chest Discomfort.

Lima R, Bezerra A, Daibes M, Domenico C, De Lorenzo A Arq Bras Cardiol. 2024; 121(6):e20230700.

PMID: 38985080 PMC: 11216331. DOI: 10.36660/abc.20230700.


Improved diagnostic accuracy for coronary artery disease detection with quantitative 3D Rb PET myocardial perfusion imaging.

Renaud J, Poitrasson-Riviere A, Moody J, Hagio T, Ficaro E, Murthy V Eur J Nucl Med Mol Imaging. 2023; 51(1):147-158.

PMID: 37721579 DOI: 10.1007/s00259-023-06414-x.


Sex- and age-specific normal values for automated quantitative pixel-wise myocardial perfusion cardiovascular magnetic resonance.

Brown L, Gulsin G, Onciul S, Broadbent D, Yeo J, Wood A Eur Heart J Cardiovasc Imaging. 2022; 24(4):426-434.

PMID: 36458882 PMC: 10029853. DOI: 10.1093/ehjci/jeac231.


EANM procedural guidelines for PET/CT quantitative myocardial perfusion imaging.

Sciagra R, Lubberink M, Hyafil F, Saraste A, Slart R, Agostini D Eur J Nucl Med Mol Imaging. 2020; 48(4):1040-1069.

PMID: 33135093 PMC: 7603916. DOI: 10.1007/s00259-020-05046-9.